H
Helga Lipari
Researcher at University of Catania
Publications - 15
Citations - 349
Helga Lipari is an academic researcher from University of Catania. The author has contributed to research in topics: Enzalutamide & Internal medicine. The author has an hindex of 7, co-authored 12 publications receiving 258 citations.
Papers
More filters
Journal ArticleDOI
Anticancer oral therapy: Emerging related issues
Giuseppe Luigi Banna,Elena Collovà,Vittorio Gebbia,Helga Lipari,Pietro Giuffrida,Sebastiano Cavallaro,Rosaria Condorelli,Calogero Buscarino,Paolo Tralongo,F. Ferraù +9 more
TL;DR: Current evidences show similar quality of life profile between oral and intravenous treatments, although anticancer oral therapy seems to be more convenient in terms of administration and reduced time lost for work or other activities.
Journal ArticleDOI
INfluenza Vaccine Indication during therapy with Immune checkpoint inhibitors: A transversal challenge. the INVIDIa study
Melissa Bersanelli,Diana Giannarelli,Paola Castrignanò,Giuseppe Fornarini,Stefano Panni,Francesca Mazzoni,Marcello Tiseo,Sabrina Rossetti,Elisabetta Gambale,Ernesto Rossi,Anselmo Papa,Alessio Cortellini,Cristian Lolli,Raffaele Ratta,Maria Michiara,Michele Milella,Emmanuele De Luca,Mariella Sorarù,Claudia Mucciarini,Francesco Atzori,Giuseppe Luigi Banna,Leonardo La Torre,Maria Giuseppa Vitale,Francesco Massari,Sara Elena Rebuzzi,Gaetano Facchini,Giovanni Schinzari,Silverio Tomao,Simona Bui,Vanja Vaccaro,Giuseppe Procopio,Ugo De Giorgi,Matteo Santoni,Corrado Ficorella,Roberto Sabbatini,Antonio Maestri,Clara Natoli,Michele De Tursi,Massimo Di Maio,Elena Rapacchi,Annagrazia Pireddu,Teodoro Sava,Helga Lipari,Francesca Comito,Elena Verzoni,Francesco Leonardi,Sebastiano Buti +46 more
TL;DR: Although influenza vaccine may be clinically ineffective in advanced cancer patients receiving CKI, it seems not to negatively impact the efficacy of anticancer therapy.
Journal ArticleDOI
Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer.
Michele Malaguarnera,Erika Cristaldi,Lisa Cammalleri,Valentina Colonna,Helga Lipari,Alessandra Capici,Andrea Cavallaro,Massimiliano Beretta,I. Alessandria,Salvatore Luca,Massimo Motta +10 more
TL;DR: The notion that the determination of serum CgA level before treatment may be a potential prognostic factor for PC is supported, as the patients with higher C gA levels had poorer prognosis and survival, as compared to those with lower CGA levels.
Journal ArticleDOI
CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases
Sabrina Paratore,Giuseppe Luigi Banna,M. D'Arrigo,Salvatore Saita,Rosario Iemmolo,Letizia Lucenti,Domenico Bellia,Helga Lipari,Calogero Buscarino,Rosario Cunsolo,Sebastiano Cavallaro +10 more
TL;DR: A possible role for the CXCL12/CXCR4 axis in the metastatic evolution of NSCLC, and its potential use as prognostic markers and drug targets is suggested.
Journal ArticleDOI
Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy
Giuseppe Luigi Banna,R. Di Quattro,Lorenzo Malatino,Giuseppe Fornarini,Alfredo Addeo,Marco Maruzzo,Valeria Urzia,Francesco Rundo,Helga Lipari,U. De Giorgi,Umberto Basso +10 more
TL;DR: NLR-5 deserves prospective validation to identify mUC patients with poor prognosis following ICIs to identify patients with metastatic urothelial cancer unlikely to benefit from immune-checkpoint inhibitors.